COMMUNIQUÉS West-GlobeNewswire

Orion Corporation: Managers’ transactions – Virve Laitinen
19/07/2019
ORION CORPORATION MANAGERS’ TRANSACTIONS 19 July 2019 at 15.45 EETS Orion Corporation: Managers’ transactions – Virve Laitinen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) [...]
SeaSpine to Report Second Quarter 2019 Financial Results on August 1, 2019
19/07/2019
CARLSBAD, Calif., July 19, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]
Momenta Pharmaceuticals Announces Date of Second Quarter 2019 Financial Results Conference Call and Webcast
19/07/2019
CAMBRIDGE, Mass., July 19, 2019 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated [...]
Alimera Sciences Announces the Appointment of Industry Veteran and Ophthalmology Business Executive John Snisarenko to its Board of Directors
19/07/2019
ATLANTA, July 19, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal [...]
Minneapolis Based MedTech SubioMed™ Start-Up Gains Certification as a Minnesota Angel Tax Credit Company
19/07/2019
MINNEAPOLIS, July 19, 2019 (GLOBE NEWSWIRE) -- SubioMed, Inc. (“SubioMed” or the “Company”), a pioneer in the invention and development of biomechanics technology addressing critical elements of gait and balance, today [...]
Dova Pharmaceuticals Announces DOPTELET® (avatrombopag) Now Commercially Available in the United States for Treatment of Chronic Immune Thrombocytopenia (ITP)
19/07/2019
DOPTELET Has Differentiated Profile as The Only Oral Thrombopoietin Receptor Agonist (TPO-RA) Approved for Treatment of ITP Without Food Type Restrictions DURHAM, N.C., July 19, 2019 (GLOBE NEWSWIRE) -- Dova [...]
Strongbridge Biopharma plc Announces New Employment Inducement Awards
19/07/2019
DUBLIN, Ireland and TREVOSE, Pa., July 19, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
Cynata confirms receipt of indicative, non-binding proposal
19/07/2019
MELBOURNE, Australia, July 19, 2019 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP) (“ Cynata ” or, the “ Company ”), a clinical-stage biotechnology company specializing in cell therapeutics, refers to the [...]
Orion Corporation: Managers’ transactions – Timo Lappalainen
19/07/2019
ORION CORPORATION MANAGERS’ TRANSACTIONS 19 July 2019 at 13.15 EETS Orion Corporation: Managers’ transactions – Timo Lappalainen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU [...]
Genmab Announces Full Exercise of Underwriters’ Over-Allotment Option in Initial Public Offering
19/07/2019
Company Announcement The 15% over-allotment option in connection with Genmab's initial public offering of American Depositary Shares in the United States and listing on the Nasdaq Global Select Market has been exercised [...]
Genmab Announces Submission of Extension of Marketing Authorization to European Medicines Agency for Subcutaneous Formulation of Daratumumab
19/07/2019
Media Release Copenhagen, Denmark; July 19, 2019 Extension of marketing authorization submitted to European Medicines Agency for subcutaneous formulation of daratumumab Submission based on data from Phase III COLUMBA [...]
Motif Bio Announces Receipt of Deficiency Notice from Nasdaq
19/07/2019
NEW YORK, July 19, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/Nasdaq: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that it has received a deficiency [...]
Change in Directors' and PDMR interests in the shares of Acacia Pharma Group plc
19/07/2019
ACACIA PHARMA GROUP PLC Change in Directors' and PDMR interests in the shares of Acacia Pharma Group plc Cambridge, UK and Indianapolis, US –19 July 2019: Acacia Pharma Group plc (“Acacia Pharma”, the "Company”, the “ [...]
Atara Biotherapeutics Announces Pricing of $150.0 Million Public Offering
19/07/2019
SOUTH SAN FRANCISCO, Calif., July 18, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Amarin Prices Public Offering of American Depositary Shares
19/07/2019
BEDMINSTER, N.J. and DUBLIN, Ireland, July 18, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today announced the pricing of the underwritten public offering of 22,222,223 American Depositary Shares (" [...]
Afya Limited Announces Pricing of Initial Public Offering
19/07/2019
NEW YORK, July 18, 2019 (GLOBE NEWSWIRE) -- Afya Limited (“ Afya ”) today announced the pricing of its initial public offering of 13,744,210 Class A common shares at a public offering price of $19.00 per share. Afya is [...]
XORTX Reports Annual & Special Meeting Results
19/07/2019
CALGARY, Alberta, July 18, 2019 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX; OTCQB: XRTXF; ANU1: FWB), a biopharmaceutical company focused on developing innovative therapies to [...]
Harvard Bioscience Names Michael Rossi Chief Financial Officer
18/07/2019
HOLLISTON, Mass., July 18, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that Michael Rossi has been named Chief Financial Officer, effective immediately. Rossi most recently served as [...]
Sientra to Report Second Quarter 2019 Financial Results on August 8, 2019
18/07/2019
SANTA BARBARA, Calif., July 18, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (Nasdaq: SIEN), a medical aesthetics company, announced today that it will release financial results for the second quarter 2019 after the close of [...]

Pages